Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Lukoil starts construction of a lubricant production complex

2/13/24 LKOH

VTB received 24.9% in Natspromleasing

2/13/24 VTBR

Yandex presented a browser with a new generation of neural networks

2/13/24 YNDX

Diasoft IPO will be held at the upper boundary of the price corridor

2/13/24 DIAS

Volume of native business advertising on VK Video exceeded ₽1 billion

2/12/24 VKCO

Polymetal acquires Sergeyevskaya Mining and Geological Company

2/12/24 POLY

Aeroflot reported for 2023 by RAS

2/12/24 AFLT

MTS Bank is preparing to hold an IPO in the spring

2/12/24 MTSS

Moscow Exchange establishes a center of information on issuers

2/12/24 MOEX

Sberbank withdraws from the capital of Rosneft's shipping company

2/12/24 SBER